{"id":"a9c01360-9785-4135-b12a-e3a72877346e","modelId":"34aec096-0484-4591-b8c1-f65bd183344f","versionId":null,"locationId":"84e0a0ff-62f3-4522-b9c6-30c1ed454ad2","operatorId":null,"ownerId":null,"slug":"cmr-versius-uk","status":"operational","firstSeen":"2019-01-01T12:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":false,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":"maker_operated","sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://cmrsurgical.com/versius/","title":"Versius surgical robot","sourceName":"CMR Surgical"},{"url":"https://cmrsurgical.com/news/versius-procedure-milestone/","title":"Versius reaches procedure milestone","sourceName":"CMR Surgical"},{"url":"https://www.royalpapworth.nhs.uk/our-hospital/latest-news/new-thoracic-surgery-robot-bought-royal-papworth-uk-first","title":"Royal Papworth Cambridge Versius thoracic Mar 2023","sourceName":"Royal Papworth NHS"},{"url":"https://www.bbc.co.uk/news/uk-england-cambridgeshire-65039708","title":"BBC: Royal Papworth robot thoracic surgery","sourceName":"BBC News"},{"url":"https://www.cambridge-news.co.uk/news/cambridge-news/addenbrookes-hospital-gets-new-surgical-27253650","title":"Addenbrookes Cambridge Versius Jul 2023","sourceName":"Cambridgeshire Live"},{"url":"https://www.mkuh.nhs.uk/news/mkuh-purchases-second-versius-system-to-bring-robotic-surgery-to-more-patients","title":"Milton Keynes second Versius Sep 2024","sourceName":"MKUH NHS"}],"notes":"Versius surgical robot systems have been deployed at multiple UK NHS hospitals, including Royal Papworth Hospital for thoracic surgery, Addenbrooke's Hospital, and Milton Keynes University Hospital, the latter of which acquired a second Versius system to expand robotic surgery availability for patients.","keyFacts":[{"date":"2024-01-01","label":"UK hospital sites","value":"~15+ NHS and private hospitals","source":"CMR Surgical operations","category":"scale"},{"date":"2019-01-01","label":"UK CA mark","value":"Active for laparoscopic procedures","source":"UK MHRA","category":"regulatory"},{"date":"2024-01-01","label":"Cumulative procedures","value":"~10,000+","source":"CMR Surgical milestones","category":"procedure_volume"}],"reviewNote":"Verified: CMR Versius UK NHS deployments. Royal Papworth Hospital Cambridge (Mar 2023, UK first for thoracic surgery). Addenbrookes Hospital Cambridge (Jul 2023, leased for upper GI/gynaecology/colorectal). Milton Keynes University Hospital (Sep 2024, second system purchased, 800 cases milestone). Aggregate record of UK NHS adoption in CMR home region.","exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-07T14:06:14.344Z","updatedAt":"2026-07-10T05:51:58.025Z","model":{"id":"34aec096-0484-4591-b8c1-f65bd183344f","companyId":"6bbb447e-0278-4ae1-822d-8b546420511e","modelName":"Versius","slug":"cmr-versius","description":"CMR Surgical (founded 2014, Cambridge, UK; private) makes Versius, the genuine challenger among surgical-robot startups and the one that has clearly crossed the regulatory gating event. Versius is a modular multi-arm teleoperated soft-tissue robot that is heavily software-driven, capturing telematic, video, and outcome data. It received US FDA De Novo marketing authorization in October 2024, the first such authorization for a multi-port soft-tissue general-surgery robot, followed by an FDA 510(k) clearance for the next-generation Versius Plus on December 18, 2025 with US commercialization on track for 2026, and a pending gynecology 510(k) submitted on April 29, 2026; it has long been CE-marked and commercial across Europe, Latin America, the Africa-Middle-East region, and Australia, with more than 40,000 procedures completed outside the US by company reporting. The registry records it at commercial maturity with an active lifecycle. An important current-state correction: the 2021 roughly $3 billion SoftBank-led valuation story is frozen in time, the company went through real restructuring in 2023 with about 350 redundancies, and it was recapitalized with more than $200 million in April 2025, while reported figures of a roughly $3.1 billion 2025 valuation and a potential $4 billion sale are rumor-tier aggregator claims that are not registered. On AI substance the shipped reality is a data-capture and analytics ecosystem with the surgeon in full control; the physical-AI framing is forward-looking, anchored in a March 2026 NVIDIA IGX Thor partnership to evaluate AI for a future Versius, with no autonomous or AI-assisted intraoperative feature cleared or shipped.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"arms":"multi-arm","notes":[{"label":"Verified","value":"CMR Surgical (founded 2014, Cambridge UK; private) makes Versius, the genuine challenger that crossed the gating event: FDA De Novo Oct 2024 (first De Novo for a multi-port soft-tissue general-surgery robot), FDA 510(k) for next-gen Versius Plus Dec 18 2025 (US commercialization on track for 2026), plus a pending gynecology 510(k) (Apr 29 2026). >40,000 procedures completed ex-US (company-reported). Recapitalized with $200M+ in Apr 2025."},{"label":"Current-state correction (peak-era framing stale)","value":"The 2021 ~$3B SoftBank-led valuation story is frozen. The company went through real 2023 restructuring (~350 redundancies). REJECTED as unverified aggregator/rumor-tier: a ~$3.1B 2025 valuation and a ~$4B sale-exploration; current valuation is unconfirmed (cap-flag)."},{"label":"AI-substance: R&D-stage (honest)","value":"Shipped substance = data-capture + analytics ecosystem (teleoperated, surgeon in full control). The 'physical AI' is forward-looking: a Mar 2026 NVIDIA IGX Thor partnership to EVALUATE AI for next-gen Versius (~500 hrs anonymized data contributed). No autonomous/AI-assist intraoperative feature is FDA-cleared or shipped."},{"label":"Claimed but NOT verified","value":"~$3.1B current valuation; ~$4B sale exploration; exact installed unit count (procedure-count >40k is self-reported); any AI-assist feature being commercially available; gynecology indication (submitted, not cleared)."}],"products":"Versius / Versius Plus: modular multi-arm soft-tissue minimal-access robot; teleoperated, software-driven (captures telematic/video/outcome data). FDA De Novo Oct 2024 (Versius, cholecystectomy); FDA 510(k) Dec 18 2025 (Versius Plus, cholecystectomy); 510(k) gynecology submission Apr 29 2026 (pending). CE-marked + commercial across Europe, Latin America, AMEA, Australia.","formFactor":"surgical (modular multi-port / multi-arm teleoperated soft-tissue surgical robot)","fda_clearance":"De Novo marketing authorization in October 2024","clearance_body":"US FDA","procedure_types":"cholecystectomy"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.globenewswire.com/news-release/2024/10/15/cmr-surgical-versius-fda-de-novo","title":"CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024)","sourceName":"CMR Surgical (GlobeNewswire)"},{"url":"https://www.therobotreport.com/cmr-surgical-receives-fda-clearance-for-versius-plus-surgical-robot/","title":"CMR Surgical FDA 510(k) for Versius Plus (Dec 18 2025; US launch 2026)","sourceName":"The Robot Report"},{"url":"https://www.massdevice.com/cmr-surgical-200-million-funding/","title":"CMR Surgical raises $200M+ to fund US/Asia commercialization (Apr 2025)","sourceName":"MassDevice"},{"url":"https://www.globenewswire.com/news-release/2026/03/17/cmr-surgical-nvidia-igx-thor","title":"CMR Surgical + NVIDIA IGX Thor (evaluating AI for next-gen Versius; R&D-stage)","sourceName":"CMR Surgical (GlobeNewswire)"},{"url":"https://www.cambridgeindependent.co.uk/news/cmr-surgical-redundancies","title":"CMR Surgical 2023 redundancies (~350; historical restructuring)","sourceName":"Cambridge Independent"}],"aliases":["Versius","Versius Plus","CMR Versius"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form factor","value":"modular multi-arm teleoperated soft-tissue surgical robot"},{"label":"Procedures completed","value":"more than 40,000 outside the US (company-reported)"},{"label":"FDA authorization","value":"De Novo marketing authorization October 2024"},{"label":"Recapitalization","value":"more than $200 million in April 2025"},{"label":"Restructuring","value":"approximately 350 redundancies in 2023"}],"createdAt":"2026-06-03T20:12:29.087Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"6bbb447e-0278-4ae1-822d-8b546420511e","name":"CMR Surgical","slug":"cmr-surgical","description":"UK surgical-robotics company (Cambridge; founded 2014) making the Versius modular multi-arm teleoperated surgical robot; FDA De Novo 2024 + Versius Plus 510(k) 2025; >40k procedures ex-US.","status":"private (recapitalized $200M+ Apr 2025; current valuation unconfirmed)","founded":2014,"hq":"Cambridge, United Kingdom","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.globenewswire.com/news-release/2024/10/15/cmr-surgical-versius-fda-de-novo","title":"CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024)","sourceName":"CMR Surgical (GlobeNewswire)"},{"url":"https://www.therobotreport.com/cmr-surgical-receives-fda-clearance-for-versius-plus-surgical-robot/","title":"CMR Surgical FDA 510(k) for Versius Plus (Dec 18 2025; US launch 2026)","sourceName":"The Robot Report"},{"url":"https://www.massdevice.com/cmr-surgical-200-million-funding/","title":"CMR Surgical raises $200M+ to fund US/Asia commercialization (Apr 2025)","sourceName":"MassDevice"},{"url":"https://www.globenewswire.com/news-release/2026/03/17/cmr-surgical-nvidia-igx-thor","title":"CMR Surgical + NVIDIA IGX Thor (evaluating AI for next-gen Versius; R&D-stage)","sourceName":"CMR Surgical (GlobeNewswire)"}],"keyFacts":[{"label":"Product","value":"Versius / Versius Plus modular multi-arm teleoperated surgical robot."},{"label":"Gating events","value":"FDA De Novo Oct 2024; Versius Plus 510(k) Dec 2025; gynecology 510(k) pending."},{"label":"wikidata","value":"https://www.wikidata.org/wiki/Q60775579"},{"label":"wikipedia","value":"https://en.wikipedia.org/wiki/CMR_Surgical"},{"label":"Founded","value":"2014, Cambridge, UK"},{"label":"Key product","value":"Versius surgical robot system"},{"label":"FDA clearance","value":"Versius Plus secured"}],"aliases":["CMR","Cambridge Medical Robotics","Versius"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:12:28.328Z","updatedAt":"2026-07-08T03:25:33.274Z"}},"version":null,"location":{"id":"84e0a0ff-62f3-4522-b9c6-30c1ed454ad2","name":"United Kingdom","slug":"united-kingdom","kind":"country","parentLocationId":null,"region":null,"lat":55.3781,"lng":-3.436,"reviewStatus":"reviewed","aliases":["UK","Britain","Great Britain"],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-05-31T04:22:22.268Z","updatedAt":"2026-07-02T22:50:37.891Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/cmr-versius-uk","url":"https://registry.deploy.report/deployments/cmr-versius-uk","name":"Versius at United Kingdom","identifier":"a9c01360-9785-4135-b12a-e3a72877346e","startDate":"2019-01-01T12:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/united-kingdom","name":"United Kingdom"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/cmr-surgical","name":"CMR Surgical"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/cmr-versius","name":"Versius"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":6,"primary_source_types":[]}}}